GINKGO BIOWORKS HOLDINGS, INC. (DNA)

Import this data to Google Sheets with:

=jivedata("DNA","financials")

Full statements spill as a table. For one cell: =jivedata("DNA","Revenue") or =jivedata("DNA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

GINKGO BIOWORKS HOLDINGS, INC.

DNA • CIK 0001830214

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Excluding Assessed Tax	$251,455	$227,043	$170,155	$111,863
Operating Income (Loss)	$-864,406	$-559,757	$-315,278	$-290,691
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-892,940	$-547,508	$-313,600	$-295,480
Income Tax Expense (Benefit)	$-71	$-479	$-837	$-594
Net Income (Loss) Attributable to Parent	$-892,869	$-547,029	$-312,763	$-290,803
Research and Development Expense	$580,621	$424,061	$243,773	$215,610
General and Administrative Expense	$385,025	$246,161	$183,290	$159,573
Operating Lease, Impairment Loss	$96,210	$0	$0	$0
Goodwill, Impairment Loss	$0	$47,858	$0	$0
Restructuring Costs and Asset Impairment Charges	—	$24,172	$11,398	$2,451
Operating Expenses	$1,115,861	$786,800	$485,433	$485,433
Interest Income, Other	$57,217	$38,612	$22,616	$22,616
InterestExpenseNonoperating	—	$94	$0	$0
Income (Loss) from Equity Method Investments	$-2,635	$0	$0	$-4,673
Gain (Loss) on Investments	$-54,827	$-28,827	$-16,411	$-11,716
Deconsolidation, Gain (Loss), Amount	$-42,502	$-7,013	$0	$0
Fair Value Adjustment of Warrants	$-5,168	$-5,701	$0	$0
Other Operating Income (Expense), Net	$9,138	$3,870	$-4,527	$-5,680
Other Nonoperating Income (Expense)	$-28,534	$12,249	$1,678	$-4,789
Weighted Average Number of Shares Outstanding, Basic	1,944,420,000	51,894,639	55,457,676	61,741,566
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-888,753	$-550,319	$-309,106	$-291,506
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent	—	—	$3,531	$3,531
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax	—	$-1,492	$0	$0
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent	—	—	$-126	$-126
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent	—	—	$3,657	$3,657

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$944,073	$561,572	$167,202	$84,535
Marketable Securities, Current	—	—	$255,418	$255,418
Property, Plant and Equipment, Net	$188,193	$203,720	$167,783	$157,185
Accounts Receivable, after Allowance for Credit Loss, Current	$17,157	$21,857	$24,026	$13,013
Operating Lease, Right-of-Use Asset	$206,801	$394,435	$360,918	$347,661
Accounts Receivable, after Allowance for Credit Loss	$742	$586	$229	$0
Equity Securities, FV-NI and without Readily Determinable Fair Value	$78,565	$48,704	$15,066	$14,775
Prepaid Expense and Other Assets, Current	$39,777	$18,729	$24,963	$17,359
Intangible Assets, Net (Excluding Goodwill)	$82,741	$72,510	$56,924	$44,387
Assets, Current	$1,001,749	$602,744	$471,838	$332,535
Other Assets, Noncurrent	$58,055	$55,336	$47,167	$1,323
Assets	$1,665,342	$1,377,449	$1,119,696	$990,046
Liabilities	$568,190	$661,391	$611,106	$569,762
Accounts Payable, Current	$9,323	$14,169	$10,566	$9,575
Contract with Customer, Liability, Current	$44,486	$27,710	$18,946	$13,214
Accrued Liabilities and Other Liabilities	$110,051	$65,387	$66,458	$49,951
Liabilities, Current	$163,860	$107,266	$95,970	$72,740
Contract with Customer, Liability, Noncurrent	$158,062	$98,783	$75,182	$76,537
Operating Lease, Liability, Noncurrent	$221,835	$438,766	$417,078	$404,113
Other Liabilities, Noncurrent	$18,733	$16,576	$22,876	$16,372
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$199	$5	$6	$6
Additional Paid in Capital	$6,385,997	$6,555,416	$6,657,053	$6,698,945
Retained Earnings (Accumulated Deficit)	$-5,290,528	$-5,837,557	$-6,150,320	$-6,279,617
Accumulated Other Comprehensive Income (Loss), Net of Tax	$1,484	$-1,806	$1,851	$950
Stockholders' Equity Attributable to Parent	—	—	$508,590	$420,284
Preferred Stock, Shares Authorized	200,000,000	200,000,000	200,000,000	200,000,000
Preferred Stock, Shares Issued	0	0	0	0
Contract with Customer, Liability	$222,600	$202,500	$126,500	$94,100

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-892,869	$-547,029	$-312,763	$-312,763
Net Cash Provided by (Used in) Operating Activities	$-295,500	$-319,585	$-171,059	$-170,243
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$-588	$-281	$201	$-145
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-379,997	$-383,841	$-393,372	$-79,336
Cash and Cash Equivalents, at Carrying Value	$944,073	$561,572	$167,202	$-1,354
Restricted Cash	$45,511	$44,171	$45,169	$46,989
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$989,584	$605,743	$212,371	$45,635
Depreciation, Depletion and Amortization, Nonproduction	$70,507	$63,020	$58,990	$52,945
Payments to Acquire Debt Securities, Available-for-sale	—	—	$418,630	$225,943
Share-based Payment Arrangement, Noncash Expense	$229,884	$112,344	$81,546	$62,316
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale	—	—	$159,483	$260,693
Goodwill, Impairment Loss	$0	$47,858	$0	$0
Proceeds from Sale of Debt Securities, Available-for-sale	—	—	$25,899	$25,899
Restructuring Costs	—	$4,823	$0	$0
Payments to Acquire Property, Plant, and Equipment	$40,801	$62,541	$7,665	$4,557
Payments to Acquire Interest in Subsidiaries and Affiliates	$42,980	$0	$0	$0
Income (Loss) from Equity Method Investments	$-2,635	$0	$0	$-4,673
Payments to Acquire Businesses, Net of Cash Acquired	$0	$5,400	$0	$0
Gain (Loss) on Investments	$-54,827	$-28,827	$-16,411	$-11,716
Payments to Acquire Notes Receivable	$350	$0	$0	$0
Proceeds from Sale and Maturity of Marketable Securities	—	$4,519	$0	$0
Fair Value Adjustment of Warrants	$-5,168	$-5,701	$0	$0
Proceeds from Sale of Property, Plant, and Equipment	$4,428	$648	$574	$574
Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High	$-9,168	$-3,214	$4,232	$0
Payments for (Proceeds from) Other Investing Activities	$990	$-538	$-50	$164
Deconsolidation, Gain (Loss), Amount	$-42,502	$-7,013	$0	$0
Net Cash Provided by (Used in) Investing Activities	$-80,693	$-62,236	$-240,289	$56,502
Gain (Loss) on Sale of Assets and Asset Impairment Charges	$-121,404	$-5,796	$0	$0
Deferred Income Tax Expense (Benefit)	$-801	$-936	$-1,364	$-1,364
Gain (Loss) on Disposition of Assets	$-842	$-844	$0	$0
Operating Lease, Right-of-Use Asset, Amortization Expense	$28,313	$28,095	$30,082	$28,473
Other Noncash Income (Expense)	$-2,147	$-1,224	$-2,064	$-1,729
Increase (Decrease) in Accounts Receivable	$-50,068	$4,725	$1,473	$-2,410
Proceeds from Issuance of Common Stock	—	—	$19,469	$36,518
Increase (Decrease) in Prepaid Expense and Other Assets	$-10,473	$-10,085	$5,247	$3,750
Payments of Stock Issuance Costs	—	—	$1,340	$1,900
Proceeds from Stock Options Exercised	$93	$84	$0	$0
Increase (Decrease) in Other Noncurrent Assets	$-2,570	$1,394	$-296	$-563
Payment, Tax Withholding, Share-based Payment Arrangement	—	—	$0	$0
Increase (Decrease) in Accounts Payable	$-1,183	$4,771	$-2,992	$-2,992
Finance Lease, Principal Payments	$1,295	$897	$354	$68
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities	$16,899	$-40,438	$10,376	$7,844
Payment for Contingent Consideration Liability, Financing Activities	$1,411	$922	$0	$0
Increase (Decrease) in Contract with Customer, Liability	$-35,917	$-68,645	$-32,393	$-14,355
IncreaseDecreaseInOperatingLeaseLiability	$-22,800	$-14,881	$-27,932	$-27,037
Net Cash Provided by (Used in) Financing Activities	$-3,216	$-1,739	$17,775	$34,550
Increase (Decrease) in Other Noncurrent Liabilities	$452	$2,094	$11,463	$183

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("DNA","financials")

Full statements spill as a table. For one cell: =jivedata("DNA","Revenue") or =jivedata("DNA","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.